Clinical trials: Stage 0 Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
A Positron Emission Tomography (PET) Imaging Agent [18F]-ODS2004436 as a Marker of EGFR Mutation in Subjects With NSCLC
The development of biomarkers will lead the dynamic of personalized medicine and fill the unsatisfied needs in oncology for prediction of therapeutic response. Molecular imaging enables non invasive quantification of biomarkers.
- Trial name
- IMKRUN 2 (NCT02847377)
- Testing
- Injection of [18F]-ODS2004436 radiotracer
- Where
- France
- Volunteers
- 20 people
- Sponsor
- Centre Georges Francois Leclerc
Lung Cancer
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
RATIONALE: Studying samples of tissue, blood, sputum, and urine from patients with lung cancer and from healthy participants in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers…
- Trial name
- NCT00899028
- Testing
- comparative genomic hybridization, fluorescence in situ hybridization, gene expression analysis
- Where
- 4 sites in United States
- Volunteers
- 689 people, healthy volunteers welcome
- Sponsor
- Vanderbilt University Medical Center
Lung Cancer
Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer
RATIONALE: Photodynamic therapy uses light and drugs that make cnacer cells more sensitive to light to kill tumor cells. Brachytherapy uses radiation to damage tumor cells.
- Trial name
- NCT00014066
- Testing
- hematoporphyrin derivative, brachytherapy
- Where
- United States
- Sponsor
- Roswell Park Cancer Institute
Lung Cancer
Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer
RATIONALE: Video-assisted surgery may be an effective treatment and have fewer side effects than conventional surgery in patients with non-small cell lung cancer.
- Trial name
- NCT00003692
- Testing
- therapeutic thoracoscopy, video-assisted surgery
- Where
- 115 sites in United States, Puerto Rico and 1 more
- Volunteers
- 128 people
- Sponsor
- Alliance for Clinical Trials in Oncology